SignalChem Diagnostics offers a selection of high-quality COVID-19 neutralizing nanobodies, designed to support innovative research in diagnostics, therapeutics, and vaccine development. Our nanobodies are engineered to target the SARS-CoV-2 Spike protein, effectively neutralizing viral entry into host cells. With their high specificity, stability, and ease of production, these nanobodies serve as valuable tools for understanding virus-host interactions and developing potential therapeutics.
| Product Name | Catalog # | Expresison Host Organism |
|---|---|---|
| Anti 2019-nCoV Spike Protein Neutralizing Nanobody (NBX20010) | C19S1-641HL | |
| Anti 2019-nCoV Spike Protein Neutralizing Nanobody (NBX20014) | C19S1-644HL | |
| Anti 2019-nCoV Spike Protein Neutralizing Nanobody (NBX20025) | C19S1-643HL | |
| Anti 2019-nCoV Spike Protein Neutralizing Nanobody (NBX20038) | C19S1-642HL | |
| Anti-2019-nCoV Spike Protein Neutralizing Nanobody (NBX20014) | C19S1-654L | |
| Anti-2019-nCoV Spike Protein Neutralizing Nanobody (NBX20025) | C19S1-653L | |
| Anti-2019-nCoV Spike Protein Neutralizing Nanobody (NBX20038) | C19S1-652L |
